• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Proveris Scientific
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Team Consulting now under team ownership

The new owners of Team Consulting

The new owners of Team Consulting

Many of the attendees at the upcoming RDD meeting in Puerto Rico who stop by Team Consulting’s table to check out the company’s Occoris inhaler probably won’t realize that the Team staff with whom they are chatting are some of the company’s new owners.

Founded in 1986, Team has developed a wide range of medical devices, including more than 20 inhalers. Until March of this year, the majority of the company’s shares were owned by co-founder Andy Fry and chairman Jerry Turner. Then in mid-March, almost 50 of Team’s employees took ownership of the company.

According to CEO Dan Flicos, the decision to sell the company to its staff just seemed like the right way to maintain the company’s commitment to excellence into the future: “One of the problems that small private companies have is how do you deal with succession. Most people reach for the venture capitalists or look to sell the company but we really, really didn’t want to do that; we wanted to keep the company owned by the staff because it has quite a special culture. We strongly, passionately believe that companies such as Team should be owned by the staff.

Flicos says that he was overwhelmed by the staff response to the buyout offer. “I think it speaks volumes for Team,” he notes, “that the employees really believe in what they do and are prepared to not only do their day job but put their hands in their pockets as well.”

Management communicated openly with the staff throughout the 14-month process that eventually led to the buyout, Flicos adds, including the earliest talks with corporate finance advisers and venture capitalists as the company explored its options. One of the biggest concerns raised by staff members with respect to a possible sale to an investor, competitor or client, he says, was the potential effect on Team’s culture.

Share
1 2Next page »

published on April 8, 2014

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • May 6-May 9: RDD Europe 2025, Estoril, Portugal
  • May 13-May 14: Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course 24, online
  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Solstice Air banner
    © 2025 OINDPnews